ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 853 out of 5176

$655K Total Retail Price of All Prescriptions

Rank: 706 out of 5176

253 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 6,046 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 449 328 1 3
AMLODIPINE BESYLATE 291 205 2 2
METFORMIN HCL 263 211 3 7
NEXIUM 248 125 4 16
SIMVASTATIN 240 158 5 1
HYDROCHLOROTHIAZIDE 211 175 6 10
METOPROLOL SUCCINATE 172 127 7 11
LISINOPRIL 159 126 8 5
ALENDRONATE SODIUM 153 105 9 18
IBUPROFEN 152 84 10 72
LOVAZA 152 94 10 43
LOSARTAN-HYDROCHLOROTHIAZIDE 150 130 12 35
ZOLPIDEM TARTRATE 139 85 13 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 75 14 49
LEVOTHYROXINE SODIUM 137 64 15 4
MELOXICAM 134 76 16 53
ADVAIR DISKUS 132 64 17 32
SINGULAIR 129 58 18 62
VOLTAREN 126 89 19 97
DONEPEZIL HCL 120 110 20 28
CRESTOR 109 67 21 15
GLYBURIDE-METFORMIN HCL 105 101 R 22 76
LOSARTAN POTASSIUM 103 98 23 14
ATORVASTATIN CALCIUM 96 89 24 9
DIOVAN HCT 96 57 24 39
FLUTICASONE PROPIONATE 90 67 26 38
DICLOFENAC SODIUM 90 71 26 160
ATENOLOL 88 65 28 12
TAMSULOSIN HCL 86 78 29 20
AMMONIUM LACTATE 85 61 30 91
PLAVIX 81 56 31 29
NAPROXEN 79 50 32 95
CLOTRIMAZOLE-BETAMETHASONE 79 50 32 94
VENTOLIN HFA 75 60 34 64
NASONEX 69 28 35 178
CELEBREX 69 16 35 80
DICLOFENAC POTASSIUM 69 36 35 575
ENALAPRIL MALEATE 69 69 35 22
CLOPIDOGREL 65 39 39 26
MECLIZINE HCL 64 26 40 81
VALACYCLOVIR 61 38 41 297
LANTUS SOLOSTAR 61 48 41 70
PROAIR HFA 60 38 43 60
ACTOS 59 44 44 85
JANUMET 56 49 45 77
PAROXETINE HCL 52 40 46 93
SYMBICORT 51 17 47 120
NAMENDA 51 45 47 47
DIOVAN 51 22 47 19
RANITIDINE HCL 51 23 47 36
LIDODERM 50 26 51 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.